knowledge -WSS

knowledge

author：explore 2025-09-06 01:57:32 - browse：558

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Telehealth options flood the market as retailers push virtual care

WSS

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

A controversial new treatment promises to make little people taller

Readout Newsletter: What happened with Sarepta's Duchenne data

Testing for cancer recurrence creates a new limbo for patients

Chimpanzees, like humans and whales, get menopause: Study

Alnylam reports growth in sales of rare disease treatments

hotspot

knowledge

focus

As demand for Covid shots wanes, Moderna seeks its next success

'Null' research findings aren't empty of meaning. Let's publish them

At least 13 dead in Texas as scorching temps continue

Why Sanofi got shellacked over its spinoff

How one medical school became remarkably diverse

When waiting feels immoral: Empathy in the emergency department

The high cost of giving birth even with insurance

Cassava reveals details — and problems — with Alzheimer's study

Medicare details structure of new drug price negotiation program

The cancer stories no one wants to hear

leisure time

Study links childhood stress with decline in older age

First Opinion Podcast: How to protect health care in times of war

Diversifying clinical trials isn't enough to close racial gaps: study

Traditional Chinese medicine benefits explored in new JAMA study

Heart disease in astronauts blamed on cosmic radiation

Diversifying clinical trials isn't enough to close racial gaps: study

entertainment

explore

hotspot

focus